|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||223.08 - 225.65|
|52 Week Range||184.50 - 256.80|
|PE Ratio (TTM)||6.98|
|Dividend & Yield||2.80 (1.25%)|
|1y Target Est||N/A|
Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Allergan Plc a score of 28. Our analysis is based on comparing Allergan Plc with the following peers – Mylan N.V., Zoetis, Inc. Class A, Merck & Co., Inc. and Abbott Laboratories (MYL-US, ZTS-US, MRK-US and ABT-US). Investment Outlook Allergan Plc has a fundamental score of 28 ... Read more (Read more...)
Shire plc (SHPG) submitted a Marketing Authorization Application (MAA) for lifitegrast for the treatment of dry eye disease in Europe.
A Goldman spokesman said that the firm believes the case is 'without merit' and that they will 'vigorously contest it.'